The next few months will determine whether Mutares can deliver on two critical promises: slashing its debt burden and unlocking a record-breaking exit from Portuguese subsidiary Efacec. With the clock ticking on a covenant waiver and two large disposals nearing completion, the German buyout firm has little room for slippage.
Management’s immediate priority is to close the sales of NEM Energy Group and Walor Precision Turning during the third quarter. Hyundai Heavy Industries Power Systems is acquiring NEM Energy, while a binding offer from Reed Capital is in hand for Walor — though worker representatives still need to give their consent. Together, these exits are central to the company’s plan to shrink outstanding bonds from €385 million at the end of 2025 to no more than €300 million by year-end. The holding has already earmarked at least €25 million for bond buybacks in the current quarter, but that pace depends on cash actually flowing in from the two sales.
Failure to complete both deals on time would put the entire deleveraging trajectory at risk. Mutares breached a financial covenant on two of its bonds earlier this year, and creditors granted a temporary exemption running until the end of June 2026. The company is confident it will meet the required ratios again, but any renewed breach would badly shake investor confidence and likely trigger more expensive refinancing terms. A structurally negative operating cash flow from the capital-intensive turnaround business means Mutares remains dependent on fresh bond issuance, making covenant compliance a constant source of market scrutiny.
On the regulatory front, an old irritant has been put to rest. Germany’s BaFin completed its review of the 2023 annual accounts and flagged only a single missing disclosure on group receivables, which Mutares has since retroactively provided. The management report passed the inspection without any objections, clearing the way for a cleaner corporate narrative.
Should investors sell immediately? Or is it worth buying Mutares?
The bigger prize, however, hangs on Efacec. Reports earlier this year surfaced that Mutares is weighing an exit from the Portuguese energy and electrical equipment company, with JPMorgan reportedly running the process. Cantor analysts have assigned a potential value of up to €420 million to the stake — a sum that would dwarf any previous disposal in Mutares’ history. Options on the table range from a full sale to an initial public offering in Lisbon, but no official announcement has been made. The deal remains, for now, a market rumour that could turn into a transformative catalyst if confirmed.
To support its expansion plans, particularly in North America, Mutares raised €105 million in a recent capital increase. The equity injection gives it some financial firepower, but the stock market has yet to reward the story. The shares currently trade at €27.05, down nearly 10% since the start of the year, and have slipped decisively below key moving averages. The 200-day average sits at €28.86, while the relative strength index points to an oversold condition. Another 16% decline would take the stock to its yearly low.
The company did deliver a €2 per share dividend for 2025, confirmed at the annual general meeting in early July, along with reaffirmed medium-term targets. Yet the share price actually weakened in the days following the AGM, reflecting lingering scepticism about the timing of the planned exits. A performance-linked supplementary dividend, which was withheld at the AGM due to insufficient exit proceeds, could be unlocked later if the NEM and Walor deals close on schedule.
Looking ahead, the half-year report due in the third quarter will serve as the next key catalyst, offering investors fresh data on the pipeline’s progress. If both signed disposals hit their target close dates, Mutares should be able to hold its deleveraging course and deliver a holding net profit of up to €200 million for the full year. Any delay — whether from labour approvals or standard closing conditions — could keep the market’s current operational skepticism firmly in place and amplify pressure on the balance sheet.
Ad
Mutares Stock: Buy or Sell?! New Mutares Analysis from July 9 delivers the answer:
The latest Mutares figures speak for themselves: Urgent action needed for Mutares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 9.
Mutares: Buy or sell? Read more here...











